Associate Program Director
Assistant Professor of Medicine
BS - University of Washington, Seattle, Washington, 1995
MHS - Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, 1999
MD - Sackler School of Medicine, Tel Aviv University; Tel Aviv, Israel, 2002
Internal Medicine, Oregon Health and Science University 2005
Infectious Disease, Oregon Health and Science University 2007
- Mycobacterial infections
- Infections in immunocompromised hostsHIV
- Immunodiagnosis of Mycobacterium tuberculosis (Mtb) infection
- Immunological Bioinformatics
- Point of care diagnostics in high burden settings for Mtb
Dr. Nyendak is the Associate Program Director for the Internal Medicine Residency and an Assistant Professor of Medicine. She is responsible for representing the subspecialty mission of the residency program which includes providing mentorship for subspecialty bound residents and those with an interest in the clinician-researcher career path, developing and maintaining curriculum within each subspecialty rotation block, and improving the overall experience of subspecialty experiences offered within the program. In addition, Dr. Nyendak oversees the Global Health Scholars Program in Internal Medicine. Her research career has focused on translating discoveries made in the host immune response to Mycobacterium tuberculosis (Mtb) infection with a view toward improved Mtb diagnostic biomarkers. Her clinical interests include infections in immune compromised hosts.
Publications and Scholarly Activities
Nyendak M, Park B, Null M, Baseke J, Swarbrick G, Mayanja-Kizza H, Nsereko M, Johnson D, Gitta P, Okwera A, Goldberg S, Bozeman L, Johnson J, Boom WH, Lewinsohn DA, Lewinsohn DM. Mycobacterium tuberculosis specific CD8+ T cells rapidly decline with antituberculosis treatment. PLOS one, In Press 2013.
Lancioni C, Nyendak M, Kiguli S, et al. CD8+ T cells Provide an Immunologic Signature of Tuberculosis in Young Children. Am J Respir Crit Care Med 2011 Oct 27.
Nyendak M, Lewinsohn DA, Lewinsohn DM. New diagnostic methods for tuberculosis. Curr Opin Infect Dis 2009 Apr;22(2):174-82.
Nyendak M, Lewinsohn DA, Lewinsohn DM. The Use of Interferon-gamma Release Assays in Clinical Practice. Clinical Tuberculosis (P Davies Editor) Hodder Arnold Publication. 2008.
Winthrop KL, Nyendak M, Calvet H, et al. Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008 Sep;3(5):1357-63.